BIOBIJOU Co., Ltd.

489460 KRX Chemicals Chemicals
KOSDAQ
₩11,790.00
+7.28%
Delayed · cached 15 min

Fair value analysis

489460
BIOBIJOU Co., Ltd.
ChemicalsChemicals
₩11,790.00
Close used for this calculation
₩5,131.90Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
32/100
Profitability8/25
Returns3/25
Balance Sheet17/25
Efficiency4/25
Growth0/25
Weak
Quality radar
32Prof.8/25Ret.3/25Eff.4/25B.Sht17/25Growth0/25

Consensus fair value

₩5,131.90
Above FV
▼ -56.5% against the close used
Model range ₩2,178.97 – ₩5,960.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩2,178.97Fair value₩5,131.90Bull₩5,960.00
FairClose
52-week traded range
52W low ₩5,960.0052W high ₩16,850.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

BIOBIJOU Co., Ltd. closed at ₩11,790.00, 129.7% above the consensus fair value of ₩5,131.90 drawn from 7 valuation models.

Financial DNA score 32/100 — Weak. P/E of 39.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩5,585.28
-52.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩5,257.43
-55.4%
√(22.5 × EPS × BVPS)
EPS=298, BVPS=4122.38 · outside Graham range (P/E 39.6, P/B 2.9) — asset-light, treat as a rough floor
P/E Fair Value
₩5,960.00
-49.4%
EPS × 20x (sector P/E)
EPS=298, Sector P/E=20x
EV/EBITDA
₩3,569.43
-69.7%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=4.97B
Book Value (P/B)
₩2,178.97
-81.5%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=4122.38, ROE=6.7%, g=3%, r=10%
Reverse DCF
₩11,790.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 16.3% | Historical: 0%
Margin of Safety
₩4,200.68
-64.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=5600.9, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.